We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Drug Products » FDA Inspection Intelligence - Webinar Recording/Transcript

Other Options

Audio Recording/Transcript - March 7, 2018

$287.00

Audio Recording/Transcript - March 7, 2018

$258.00

Audio Recording/Transcript - March 7, 2018

$244.00

Audio Recording/Transcript - March 7, 2018

$230.00

Audio Recording/Transcript - March 7, 2018

$215.00

FDA Inspection Intelligence - Webinar Recording/Transcript

$287.00
Drug Products

Product Details

FDA Inspection Intelligence: New Focus on Data Integrity and cGMP Compliance

Drug and biologics makers are facing increased scrutiny of data integrity as an energized FDA deploys new tools to empower inspectors and concerns rise over Forms 483 and warning letters.

Mark I. Schwartz Esq. has seen it from the inside as former Deputy Director of OCBQ, CBER. Now in private practice, he advises clients like you on staying a step ahead of inspectors. Mark will spend 90 minutes mapping this new FDA crackdown, with fresh details on:

  • Background: Why the FDA is stepping up pursuit of data integrity issues now
  • The product adulteration threat: How FDA may invoke the FDASIA provision when companies balk at inspections
  • Sec. 704(a)(4): Why the agency may invoke this provision regarding advance request of records or in lieu of an inspection
  • The draft Quality Metrics initiative: Where it stands
  • And much more!

Here’s a rare chance to spend 90 minutes with an ex-insider still intimately involved with CBER inspections as a lawyer in private practice, and not pay a penny in sky-high hourly legal fees. So don’t delay.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing